eazyplex® Candida auris

Rapid molecular diagnostic test for the direct detection of Candida auris — a multidrug-resistant yeast that poses a serious risk of healthcare-associated outbreaks and is often difficult to identify with conventional laboratory methods.

More detailed product information

eazyplex® Candida auris is a lyophilized, ready-to-use CE-IVD assay designed for rapid in vitro detection of C. auris DNA directly from clinical swabs (e.g., skin or pharyngeal) or from yeast cultures. Results are displayed in real-time without the need for a separate DNA extraction step, simplifying workflow and reducing turnaround time.

How It Works

LAMP technology enables fast and specific amplification of Candida auris DNA.
No DNA extraction required — sample can be added directly to the reaction mix.
25-minute turnaround from swab or culture to result.
Includes internal inhibition control to guard against false negatives due to reaction inhibition.

Key Benefits

Rapid results supporting early detection and infection control.
Ready to use reagents — minimal hands-on time.
No DNA extraction simplifies laboratory workflow.
High performance — studies report strong agreement with culture and high sensitivity/specificity in surveillance samples.

Practical Use

The test is intended primarily for clinical microbiology and infection control laboratories that need fast, reliable detection of Candida auris colonization or infection from swab samples or cultured isolates. Rapid identification helps guide hygiene measures, outbreak management, and appropriate antifungal therapy.

For more information, please contact us by e-mail: diagnostika@pentagen.cz